Online coping program for people who inject drugs, supporting HIV and hepatitis C care
Tests an online coping skills program in 40 people who inject drugs.
Key facts
- Who runs it
- University of Georgia
- Where
- Colbert, United StatesSee the site
- Trial code
- Registry title
- Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Pilot Testing: Aim3)
- Status
- Not yet recruiting
- People taking part
- 50 people, planned
- Started
- 1 Aug 2026
- Expected to end
- 31 Jul 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Telehealth Behavioral Intervention for promoting HIV and HCV care and MOUD among Persons who inject drugs (PWID)
- Record updated
- 18 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who actively inject drugs, are HIV negative and live in rural areas. It tests a telehealth program over 8 weekly sessions.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Actively injecting drugs, shown by visible needle tracks
- Biomarker or test result
- HIV negative
Main reasons for not taking part
- Living with HIV
- Living in an urban area
- Not proficient in English
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- People who actively inject drugs verified by visible injection stigmata (needle tracks)
- HIV negative
- Adult (≥18 years)
- lives in rural areas
Who cannot take part
- Living with HIV
- Lives in urban areas
- Not proficient in English
Where in United States
- MedLink GeorgiaColbert, United StatesContact: Mohammad Rifat Haider, Ph.D.Not yet recruiting
About the trial
What the trial wants to find out
Evaluate the feasibility, acceptability, and usability of the intervention (primary outcomes) and coping skills and resilience (secondary outcomes) of the telehealth intervention over two months (8 weekly sessions) in a waitlist-controlled, randomized pilot trial using a cross-over design among 40 PWID. The primary outcomes will be feasibility, acceptability, and usability of the intervention. Secondary outcomes will be increased coping skills and resilience, which in turn, will increase status neutral HIV and HCV care and MOUD uptake (longer-term outcomes). Outcomes will be assessed using pre- and post-intervention surveys.
The 2 groups in the trial
- InterventionTreatment being tested
Treatment: Telehealth Behavioral Intervention for promoting HIV and HCV care and MOUD among Persons who inject drugs (PWID)
- Waitlist ControlExisting treatment, for comparison
Control
Treatment: Telehealth Behavioral Intervention for promoting HIV and HCV care and MOUD among Persons who inject drugs (PWID)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South
- Plain-language title
- Online coping program for people who inject drugs, supporting HIV and hepatitis C careGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 18 December 2025